Baird downgrades Medpace stock rating to neutral, raises target to $547

Investing_ng | 08-07-2026 09:07pm |

Baird downgrades Medpace stock rating to neutral, raises target to $547

Related Articles

Kwara commiserates with Plateau over sch... Top
Portraits Of Divinity, Paradox Of Faith ... Top
Cholera: Sanwo-Olu talks tough on enviro... Top
Former Senate President, Anyim, Ogba, du... Top
Kalu rallies support for Tinubu in South... Top
Adamawa Polls: PDP Clears All Chairmansh... Top

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News